Blog

Nov 11, 2024, 16:57

Advancing Precision Oncology with Biomarker Discovery Through Multiplexed Tissue Imaging

Jean-Charles Soria, Senior Vice President and Oncology Therapeutic Area Head at Amgen, shared a post on LinkedIn:

”Biomarker discovery through highly multiplexed tissue imaging is a critical step for precision oncology. It identifies complex patterns in tumors, paving the way for novel predictive biomarkers and treatment approaches.”

Highly Multiplexed Tissue Imaging in Precision Oncology and Translational Cancer Research

Authors: Alina Bollhagen, Bernd Bodenmiller.

Alina Bollhagen Bernd Bodenmiller biomarker cancer Cancer Biomarkers Jean-Charles Soria OncoDaily Oncology Precision Medicine Predictive biomarker tumor

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Special Coverage